Skip to main content

Articles

Page 1 of 14

  1. Despite demonstrated efficacy, medication treatment for opioid use disorder (MOUD) remain inaccessible to many patients, with barriers identified at the individual, clinic and system level. A wide array of imp...

    Authors: Jessica J. Wyse, Katherine Mackey, Travis I. Lovejoy, Devan Kansagara, Anais Tuepker, Adam J. Gordon, P. Todd Korthuis, Anders Herreid-O’Neill, Beth Williams and Benjamin J. Morasco
    Citation: Addiction Science & Clinical Practice 2022 17:32
  2. Pregaming is a high-drink context popular among college students that often leads to elevated blood alcohol levels and negative consequences. Over 15 years of research studies have demonstrated that pregaming ...

    Authors: Eric R. Pedersen, Justin F. Hummer, Jordan P. Davis, Reagan E. Fitzke, Nina C. Christie, Katie Witkiewitz and John D. Clapp
    Citation: Addiction Science & Clinical Practice 2022 17:31
  3. Until recently, few carceral facilities offered medications for opioid use disorder (MOUD). Although more facilities are adopting MOUD, much remains to be learned about addressing implementation challenges rel...

    Authors: Noa Krawczyk, Sachini Bandara, Sydney Merritt, Hridika Shah, Alexandra Duncan, Brendan McEntee, Maria Schiff, N. Jia Ahmad, Sara Whaley, Amanda Latimore and Brendan Saloner
    Citation: Addiction Science & Clinical Practice 2022 17:30
  4. A cessation program for hospitalized smokers is an effective strategy to achieve smoking abstinence. The effects of multiple in-hospital counseling sessions on 6-month smoking abstinence require further invest...

    Authors: Chin-Wei Kuo, Chuan-Yu Chen, Chih-Hsing Wu, Chang-Wen Chen, Fei-Ran Guo and Szu-Chun Yang
    Citation: Addiction Science & Clinical Practice 2022 17:29
  5. The 2016 U.S. Centers for Disease Control Opioid Prescribing Guideline (CDC Guideline) is currently being revised amid concern that it may be harmful to people with chronic pain on long-term opioid therapy (CP...

    Authors: Gabriela Cedillo, Mary Catherine George, Richa Deshpande, Emma K. T. Benn, Allison Navis, Alexandra Nmashie, Alina Siddiqui, Bridget R. Mueller, Yosuke Chikamoto, Linda Weiss, Maya Scherer, Alexandra Kamler, Judith A. Aberg, Barbara G. Vickrey, Angela Bryan, Brady Horn…
    Citation: Addiction Science & Clinical Practice 2022 17:28
  6. Subcutaneously retained needle fragments in people who inject drugs (PWIDs) are a possible cause of local symptoms, most commonly pain and infections. It remains unknown how common retained needle fragments ar...

    Authors: Heidi Laukkala, Otso Arponen, Mika O Murto and Olli PO Nevalainen
    Citation: Addiction Science & Clinical Practice 2022 17:27
  7. Social networks may play positive and negative roles in the lives of young adults experiencing homelessness (YEH) who are transitioning into housing. Social networks can influence their alcohol and/or other dr...

    Authors: David P. Kennedy, Karen Chan Osilla and Joan S. Tucker
    Citation: Addiction Science & Clinical Practice 2022 17:26
  8. Drug overdose rates in the United States have been steadily increasing, particularly in rural areas. The COVID-19 pandemic and associated mitigation strategies may have increased overdose risk for people who u...

    Authors: Suzan M. Walters, Rebecca S. Bolinski, Ellen Almirol, Stacy Grundy, Scott Fletcher, John Schneider, Samuel R. Friedman, Lawrence J. Ouellet, Danielle C. Ompad, Wiley Jenkins and Mai T. Pho
    Citation: Addiction Science & Clinical Practice 2022 17:24
  9. Opioid use disorders (OUD), co-occurring with either depression and/or PTSD, are prevalent, burdensome, and often receive little or low-quality care. Collaborative care is a service delivery intervention that ...

    Authors: Karen Chan Osilla, Alex R. Dopp, Katherine E. Watkins, Venice Ceballos, Brian Hurley, Lisa S. Meredith, Isabel Leamon, Vanessa Jacobsohn and Miriam Komaromy
    Citation: Addiction Science & Clinical Practice 2022 17:25
  10. Aboriginal and Torres Strait Islander (‘Indigenous’) Australians experience a greater burden of disease from alcohol consumption than non-Indigenous peoples. Brief interventions can help people reduce their co...

    Authors: James H. Conigrave, K. S. Kylie Lee, Paul S. Haber, Julia Vnuk, Michael F. Doyle and Katherine M. Conigrave
    Citation: Addiction Science & Clinical Practice 2022 17:23
  11. An increasing number of individuals who use drugs in North America are preferentially consuming fentanyl over other opioids. This has significant consequences on the treatment and management of opioid use diso...

    Authors: Pouya Azar, Jean N. Westenberg, Martha J. Ignaszewski, James S. H. Wong, George Isac, Nickie Mathew and R. Michael Krausz
    Citation: Addiction Science & Clinical Practice 2022 17:22
  12. Authors: Joanne G. Patterson, Tia N. Borger, Jessica L. Burris, Mark Conaway, Robert Klesges, Amie Ashcraft, Lindsay Hauser, Connie Clark, Lauren Wright, Sarah Cooper, Merry C. Smith, Mark Dignan, Stephenie Kennedy-Rea, Electra D. Paskett, Roger Anderson and Amy K. Ferketich
    Citation: Addiction Science & Clinical Practice 2022 17:21

    The original article was published in Addiction Science & Clinical Practice 2022 17:11

  13. Alcohol use increases risk for morbidity and mortality and is associated with over 3 million annual deaths worldwide. Contingency Management (CM) is one of the most effective interventions for substance use di...

    Authors: Crystal L. Smith, Nicole M. Rodin, Julie Y. Hwang, André Q. C. Miguel, Kim Johnson, Michael G. McDonell and Sterling M. McPherson
    Citation: Addiction Science & Clinical Practice 2022 17:20
  14. Alcohol use is a significant risk factor for disability and death in U.S. adults, and approximately one out of every six Veterans seen in primary care (PC) report unhealthy alcohol use. Unhealthy alcohol use i...

    Authors: Rachel L. Bachrach, Matthew Chinman, Keri L. Rodriguez, Maria K. Mor, Kevin L. Kraemer, Cécile E. Garfunkel and Emily C. Williams
    Citation: Addiction Science & Clinical Practice 2022 17:19
  15. The present study aimed to evaluate the results of a theory-based and systematic intervention on Hookah Tobacco Smoking (HTS) cessation in women local to Bandar Abbas, Iran.

    Authors: Sakineh Dadipoor, Ali Heyrani, Mehdi Mirzaei-Alavijeh, Teamur Aghamolaei, Mohtasham Ghaffari and Amin Ghanbarnejad
    Citation: Addiction Science & Clinical Practice 2022 17:18
  16. Disadvantage and transgenerational trauma contribute to Aboriginal and Torres Strait Islander (Indigenous) Australians being more likely to experience adverse health consequences from alcohol and other drug us...

    Authors: James H. Conigrave, Scott Wilson, Katherine M. Conigrave, Tanya Chikritzhs, Noel Hayman, Angela Dawson, Robert Ali, Jimmy Perry, Michelle S. Fitts, Louisa Degenhardt, Michael Doyle, Sonya Egert, Tim Slade, Nadine Ezard, Monika Dzidowska and K. S. Kylie Lee
    Citation: Addiction Science & Clinical Practice 2022 17:17
  17. Morbidity and mortality related to opioid use disorder (OUD) in the U.S. is at an all-time high. Innovative approaches are needed to address gaps in retention in treatment with medications for opioid use disor...

    Authors: Jacqueline Hodges, Marika Waselewski, William Harrington, Taylor Franklin, Kelly Schorling, Jacqueline Huynh, Alexa Tabackman, Kori Otero, Karen Ingersoll, Nassima Ait-Daoud Tiouririne, Tabor Flickinger and Rebecca Dillingham
    Citation: Addiction Science & Clinical Practice 2022 17:16
  18. Medication treatment for opioid use disorder (OUD) (MOUD; buprenorphine and methadone) reduces opioid use and overdose. Discontinuation of MOUD can quickly lead to relapse, overdose and death. Few persons who ...

    Authors: Breanne E. Biondi, Brent Vander Wyk, Esther F. Schlossberg, Albert Shaw and Sandra A. Springer
    Citation: Addiction Science & Clinical Practice 2022 17:15
  19. The prevalence of alcohol use disorder (AUD) among women in South Korea has been rising, causing public health problems. Yet women’s treatment needs are mostly unmet in South Korea due to the lack of women-foc...

    Authors: Insuk Lee, Mihyoung Lee and Scott Seung W. Choi
    Citation: Addiction Science & Clinical Practice 2022 17:14
  20. We have previously shown that service-wide support can increase the odds of alcohol screening in any 2-month period in a cluster randomized trial of service-wide support to Aboriginal and Torres Strait Islande...

    Authors: Monika Dzidowska, Jacques E. Raubenheimer, Timothy A. Dobbins, K. S. Kylie Lee, Noel Hayman, Julia Vnuk, Paul Haber and Katherine M. Conigrave
    Citation: Addiction Science & Clinical Practice 2022 17:13
  21. The cervical cancer burden is high among women living in Appalachia. Cigarette smoking, a cervical cancer risk factor, is also highly prevalent in this population. This project aims to increase smoking cessati...

    Authors: Joanne G. Patterson, Tia N. Borger, Jessica L. Burris, Mark Conaway, Robert Klesges, Amie Ashcraft, Lindsay Hauser, Connie Clark, Lauren Wright, Sarah Cooper, Merry C. Smith, Mark Dignan, Stephenie Kennedy-Rea, Electra D. Paskett, Roger Anderson and Amy K. Ferketich
    Citation: Addiction Science & Clinical Practice 2022 17:11

    The Correction to this article has been published in Addiction Science & Clinical Practice 2022 17:21

  22. Substance use disorders, depression and anxiety disproportionately affect people with HIV (PWH) and lead to increased morbidity and mortality. Routine screening can help address these problems but is underutil...

    Authors: Alexandra N. Lea, Andrea Altschuler, Amy S. Leibowitz, Tory Levine-Hall, Jennifer McNeely, Michael J. Silverberg and Derek D. Satre
    Citation: Addiction Science & Clinical Practice 2022 17:10
  23. Alcohol use disorder (AUD) is one of the leading etiologies for liver cirrhosis and liver transplantation. Few individuals with AUD receive guideline-based care in the form of screening, brief intervention, re...

    Authors: Emily Johnson, Sumantra Monty Ghosh, Vijay John Daniels, T. Cameron Wild, Puneeta Tandon and Ashley Hyde
    Citation: Addiction Science & Clinical Practice 2022 17:9
  24. Interventions are needed to improve the quality of South Africa’s substance use disorder (SUD) treatment system. This study aimed to identify factors associated with patient-reported suboptimal access, quality...

    Authors: Bronwyn Myers, J. Randy Koch, Kim Johnson and Nadine Harker
    Citation: Addiction Science & Clinical Practice 2022 17:8
  25. To address the US opioid epidemic, there is an urgent clinical need to provide persons with opioid use disorder (OUD) with effective medication treatments for OUD (MOUD). Formulations of sublingual buprenorphi...

    Authors: Ismene Petrakis, Sandra A. Springer, Cynthia Davis, Elizabeth Ralevski, Lucy Gu, Robert Lew, John Hermos, Melynn Nuite, Adam J. Gordon, Thomas R. Kosten, Edward V. Nunes, Robert Rosenheck, Andrew J. Saxon, Robert Swift, Alexa Goldberg, Robert Ringer…
    Citation: Addiction Science & Clinical Practice 2022 17:6
  26. Medications to treat opioid use disorder (OUD) including buprenorphine products are evidence-based and cost-effective tools for combating the opioid crisis. However, limited availability to buprenorphine is pe...

    Authors: Kevin P. Conway, Dalia Khoury, Rainer Hilscher, Arnie P. Aldridge, Stephanie J. Parker and Gary A. Zarkin
    Citation: Addiction Science & Clinical Practice 2022 17:5
  27. Extended-release buprenorphine (XRB) offers a novel approach to sustained monthly treatment for people who use opioids in criminal justice settings (CJS). This study explores the experiences of adults receivin...

    Authors: Anna Cheng, Ryan Badolato, Andrew Segoshi, Ryan McDonald, Mia Malone, Kumar Vasudevan, Beita Badiei, Allison Sugarman, Ross Macdonald, Jasdeep Mangat, Jonathan Giftos, Joshua D. Lee and Babak Tofighi
    Citation: Addiction Science & Clinical Practice 2022 17:4
  28. A quarter of pregnant women use alcohol, 6.5/1000 deliveries are affected by opioid use disorder (OUD), and the prevalence of cannabis use in pregnant women is increasing. However, marijuana co-exposure in pol...

    Authors: Kimberly Page, Cristina Murray-Krezan, Lawrence Leeman, Mary Carmody, Julia M. Stephen and Ludmila N. Bakhireva
    Citation: Addiction Science & Clinical Practice 2022 17:3
  29. Smoking cessation is the most effective means of slowing the decline of lung function associated with chronic obstructive pulmonary disease (COPD). While effective smoking cessation treatments are available, t...

    Authors: Elizabeth R. Stevens, Lei Lei, Charles M. Cleland, Mahathi Vojjala, Omar El-Shahawy, Kenneth I. Berger, Thomas R. Kirchner and Scott E. Sherman
    Citation: Addiction Science & Clinical Practice 2022 17:2
  30. Chronic obstructive pulmonary disease (COPD) causes 3 million deaths each year, yet 38% of COPD patients continue to smoke. Despite proof of effectiveness and universal guideline recommendations, smoking cessa...

    Authors: Samir Gupta, Puru Panchal, Mohsen Sadatsafavi, Parisa Ghanouni, Don Sin, Smita Pakhale, Teresa To, Zafar Zafari and Laura Nimmon
    Citation: Addiction Science & Clinical Practice 2022 17:1
  31. In the United States, methadone for opioid use disorder (OUD) is limited to highly regulated opioid treatment programs (OTPs), rendering it inaccessible to many patients. The “72-hour rule” allows non-OTP prov...

    Authors: Jordana Laks, Jessica Kehoe, Natalija M. Farrell, Miriam Komaromy, Jonathan Kolodziej, Alexander Y. Walley and Jessica L. Taylor
    Citation: Addiction Science & Clinical Practice 2021 16:73
  32. In the United States, methadone for opioid use disorder (OUD) is highly regulated. Federal agencies announced guidelines in March 2020 allowing for relaxation of take-home methadone dispensing at opioid treatm...

    Authors: Ximena A. Levander, Kim A. Hoffman, John W. McIlveen, Dennis McCarty, Javier Ponce Terashima and P. Todd Korthuis
    Citation: Addiction Science & Clinical Practice 2021 16:72
  33. Poppy seeds contain morphine and other opioid alkaloids and are commercially available in the United States. Users of poppy seed tea (PST) can consume several hundred morphine milligram equivalents per day, an...

    Authors: Scott Hagan, Carol E. Achtmeyer, Carly Hood, Eric J. Hawkins and Emily C. Williams
    Citation: Addiction Science & Clinical Practice 2021 16:71
  34. Patients with opioid use disorder (OUD) display an interindividual variability in their response to medications for opioid use disorder (MOUD). A genetic basis may explain the variability in this response. How...

    Authors: Caroul Chawar, Alannah Hillmer, Stephanie Sanger, Alessia D’Elia, Balpreet Panesar, Lucy Guan, Dave Xiaofei Xie, Nandini Bansal, Aamna Abdullah, Flavio Kapczinski, Guillaume Pare, Lehana Thabane and Zainab Samaan
    Citation: Addiction Science & Clinical Practice 2021 16:70
  35. The Problematic Online Gaming Questionnaire (POGQ) is an 18-item self-rated measure designed to assess the degree of problematic online gaming. This study translated the POGQ into Japanese (POGQ-J) and examine...

    Authors: Kazuya Inoue, Kengo Yokomitsu, Tomonari Irie, Makoto Matsuyama and Masanori Tanaka
    Citation: Addiction Science & Clinical Practice 2021 16:69
  36. The COVID-19 pandemic has exerted a significant toll on the lives of people who use opioids (PWUOs). At the same time, more flexible regulations around provision of opioid use disorder (OUD) services have led ...

    Authors: Noa Krawczyk, Adetayo Fawole, Jenny Yang and Babak Tofighi
    Citation: Addiction Science & Clinical Practice 2021 16:68
  37. The CHOICES study randomized participants with HIV and opioid use disorder (OUD) to HIV clinic-based extended-release naltrexone (XR-NTX), which requires complete cessation of opioid use, versus treatment-as-u...

    Authors: Kim A. Hoffman, Robin Baker, Laura C. Fanucchi, Paula J. Lum, Lynn E. Kunkel, Javier Ponce Terashima, Dennis McCarty, Petra Jacobs and P. Todd Korthuis
    Citation: Addiction Science & Clinical Practice 2021 16:67
  38. The emergency department (ED) offers an important opportunity to identify patients with opioid use disorder (OUD) and initiate treatment. However, post-ED follow-up is challenging, and novel approaches to enha...

    Authors: Kathryn Hawk, Caitlin Malicki, Jeremiah Kinsman, Gail D’Onofrio, Andrew Taylor and Arjun Venkatesh
    Citation: Addiction Science & Clinical Practice 2021 16:66
  39. Few studies have examined links between current alcohol dependence and specific harms among Indigenous Australians. We investigated these associations as well as help seeking for drinking, awareness of local t...

    Authors: Teagan J. Weatherall, James H. Conigrave, Katherine M. Conigrave, Jimmy Perry, Scott Wilson, Robin Room, Tanya Chikritzhs and K. S. Kylie Lee
    Citation: Addiction Science & Clinical Practice 2021 16:65
  40. Medications for opioid use disorder such as opioid agonist treatment (OAT, including methadone, buprenorphine) are the gold standard intervention for opioid use disorder (OUD). Persons with OUD have high rates...

    Authors: Travis M. Scott, Julia Arnsten, James Patrick Olsen, Franchesca Arias, Chinazo O. Cunningham and Monica Rivera Mindt
    Citation: Addiction Science & Clinical Practice 2021 16:64
  41. Alcohol is challenging to discuss, and patients may be reluctant to disclose drinking partly because of concern about being judged. This report presents an overview of the development of a medications review i...

    Authors: Jim McCambridge, Karl Atkin, Ranjita Dhital, Brent Foster, Brendan Gough, Mary Madden, Stephanie Morris, Ronan O’Carroll, Margaret Ogden, Anne Van Dongen, Sue White, Cate Whittlesea and Duncan Stewart
    Citation: Addiction Science & Clinical Practice 2021 16:63
  42. Opioid-related overdoses and harms have been declared a public health emergency in the United States, highlighting an urgent need to implement evidence-based treatments. Contingency management (CM) is one of t...

    Authors: Sara J. Becker, Cara M. Murphy, Bryan Hartzler, Carla J. Rash, Tim Janssen, Mat Roosa, Lynn M. Madden and Bryan R. Garner
    Citation: Addiction Science & Clinical Practice 2021 16:61
  43. Methamphetamine/amphetamine use has sharply increased among people with opioid use disorder (OUD). It is therefore important to understand whether and how use of these substances may impact receipt of, and out...

    Authors: Madeline C. Frost, Hannah Lampert, Judith I. Tsui, Matthew D. Iles-Shih and Emily C. Williams
    Citation: Addiction Science & Clinical Practice 2021 16:62
  44. Emergency Departments (EDs) are important arenas for the detection of unhealthy substance use. Screening, Brief Intervention, and Referral to Treatment (SBIRT) for unhealthy alcohol use has been used in some E...

    Authors: Ditte Maria Sivertsen, Ulrik Becker, Ove Andersen and Jeanette Wassar Kirk
    Citation: Addiction Science & Clinical Practice 2021 16:60
  45. Urine drug screening (UDS) is commonly used as part of treatment for opioid use disorder (OUD), including treatment with buprenorphine-naloxone for OUD in a primary care setting. Very little is known about th...

    Authors: Halle G. Sobel, Jill S. Warrington, Samuel Francis-Fath, Abigail M. Crocker and Claudia A. Berger
    Citation: Addiction Science & Clinical Practice 2021 16:59
  46. Stimulant use has increased across the US, with concomitant opioid and methamphetamine use doubling between 2011 and 2017. Shifting patterns of polysubstance use have led to rising psychostimulant-involved dea...

    Authors: Mimi Yen Li, George A. Alba, Julian Mitton and Benjamin Bearnot
    Citation: Addiction Science & Clinical Practice 2021 16:57
  47. Nonmedical use of prescription opioids (defined as taking opioid medications for hedonic effects or in a manner other than prescribed) and the use of heroin have emerged in recent years as major public health ...

    Authors: Elizabeth J. D’Amico, Daniel L. Dickerson, Anthony Rodriguez, Ryan A. Brown, David P. Kennedy, Alina I. Palimaru, Carrie Johnson, Rosanna Smart, David J. Klein, Jennifer Parker, Keisha McDonald, Michael J. Woodward and Ninna Gudgell
    Citation: Addiction Science & Clinical Practice 2021 16:56

Affiliated with

Annual Journal Metrics

Archival content

Addiction Science & Clinical Practice was formerly published by NIDA and previous issues of the journal can be viewed here.